Literature DB >> 18568291

Applications of radiotherapy and radiosurgery in the management of pediatric Cushing's disease: a review of the literature and our experience.

Jay Jagannathan1, Adam S Kanter, Claire Olson, Jonathan H Sherman, Edward R Laws, Jason P Sheehan.   

Abstract

Surgical extirpation of pituitary adenomas is considered the mainstay of therapy in pediatric patients with Cushing's disease. However, a small subset of patients will require adjuvant therapy either due to tumor invasiveness, or disease recurrence. Conventional radiation therapy (or radiotherapy) delivers ionizing radiation to control hormonally active cells in fractionated doses (spread out over time) in order to give normal cells time to recover, while radiosurgery involves focusing a high dose of radiation structures in a single treatment session to the adenoma while generally sparing the normal gland and surrounding of any substantial amount of radiation. This paper reviews the effectiveness of radiation in the treatment of pediatric Cushing's disease.

Entities:  

Mesh:

Year:  2008        PMID: 18568291     DOI: 10.1007/s11060-008-9641-2

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  65 in total

Review 1.  Radiation oncogenesis in relation to the treatment of pituitary tumours.

Authors:  A Jones
Journal:  Clin Endocrinol (Oxf)       Date:  1991-11       Impact factor: 3.478

2.  Clinical experience with image-guided robotic radiosurgery (the Cyberknife) in the treatment of brain and spinal cord tumors.

Authors:  S D Chang; M Murphy; P Geis; D P Martin; S L Hancock; J R Doty; J R Adler
Journal:  Neurol Med Chir (Tokyo)       Date:  1998-11       Impact factor: 1.742

3.  Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas.

Authors:  K Kajiwara; K Saito; K Yoshikawa; S Kato; T Akimura; S Nomura; H Ishihara; M Suzuki
Journal:  Minim Invasive Neurosurg       Date:  2005-04

4.  Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma.

Authors:  M Brada; D Ford; S Ashley; J M Bliss; S Crowley; M Mason; B Rajan; D Traish
Journal:  BMJ       Date:  1992-05-23

5.  Treatment of Cushing's disease in childhood and adolescence by stereotactic pituitary irradiation.

Authors:  M Thorén; T Rähn; B Hallengren; P H Kaad; K O Nilsson; H Ravn; M Ritzén; K E Petersen; D Aarskog
Journal:  Acta Paediatr Scand       Date:  1986-05

6.  The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease.

Authors:  J Estrada; M Boronat; M Mielgo; R Magallón; I Millan; S Díez; T Lucas; B Barceló
Journal:  N Engl J Med       Date:  1997-01-16       Impact factor: 91.245

7.  Radiosurgical management of benign cavernous sinus tumors: dose profiles and acute complications.

Authors:  J C Chen; S L Giannotta; C Yu; Z Petrovich; M L Levy; M L Apuzzo
Journal:  Neurosurgery       Date:  2001-05       Impact factor: 4.654

8.  Treatment of prolactinomas with megavoltage radiotherapy.

Authors:  A Grossman; B L Cohen; M Charlesworth; P N Plowman; L H Rees; J A Wass; A E Jones; G M Besser
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

9.  Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.

Authors:  M A Magiakou; G Mastorakos; M T Gomez; S R Rose; G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

10.  Long-term follow-up of meningiomas of the cavernous sinus after surgical treatment alone.

Authors:  Marc Sindou; Ernesto Wydh; Emmanuel Jouanneau; Mustapha Nebbal; Thomas Lieutaud
Journal:  J Neurosurg       Date:  2007-11       Impact factor: 5.115

View more
  2 in total

1.  Factors affecting early versus late remission in acromegaly following stereotactic radiosurgery.

Authors:  Mohana Rao Patibandla; Zhiyuan Xu; Jason P Sheehan
Journal:  J Neurooncol       Date:  2018-02-07       Impact factor: 4.130

Review 2.  Quality of life and other outcomes in children treated for Cushing syndrome.

Authors:  Margaret F Keil
Journal:  J Clin Endocrinol Metab       Date:  2013-05-02       Impact factor: 5.958

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.